In 1985, nerve-sparing prostatectomy, designed to preserve potency and urinary continence, was introduced. This procedure resulted in markedly improved sexual function and erectile function outcomes.

In the Western world, prostate cancer is the most common cancer in men and the second most common cause of cancer death in men.¹ Widespread adoption of prostate-specific antigen (PSA) testing and prostate biopsy has increased the detection of clinically localized prostate cancer, resulting in increased use of radical prostatectomy (RP).